Back to Search Start Over

Anticuerpos antifosfatidilserina/protrombina en pacientes con poliarteritis nodosa.

Authors :
Sánchez-Cubías, Susy Marcela
Martín-Nares, Eduardo
Hernández-Molina, Gabriela
Nuñez-Alvarez, Carlos A.
Sedano-Montoya, Manuel Antonio
Vargas-Ruiz, Angel Gabriel
Hinojosa-Azaola, Andrea
Source :
Reumatología Clínica. Nov2021, Vol. 17 Issue 9, p521-524. 4p.
Publication Year :
2021

Abstract

Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have been described in cutaneous Polyarteritis Nodosa (PAN) in association with specific manifestations. To determine aPS/PT antibodies in patients with PAN and its correlation with clinical manifestations. Cross-sectional comparative study including PAN patients and 20 controls (10 Microscopic Polyangiitis [MPA] and 10 Behçet's disease [BD]). Clinical and demographic variables, treatment, serological markers, prognosis, activity and damage indexes were evaluated. aPS/PT, anti-cardiolipin (aCL), anti-beta 2 glycoprotein 1 (anti-B2GP1) antibodies, and lupus anticoagulant (LA) were determined. Fourteen patients with PAN were included, 11 (79%) women, with disease duration of 207 months, and mostly inactive disease. Only one patient with PAN and one with BD were positive for aPS/PT IgG. LA was the most frequent antibody identified. One patient with MPA and one with BD were positive for aCL IgM; one with MPA for anti-B2GP1 IgG, and one with PAN for anti-B2GP1 IgM. aPS/PT antibodies are not frequent in patients with longstanding inactive PAN. [ABSTRACT FROM AUTHOR]

Details

Language :
Spanish
ISSN :
1699258X
Volume :
17
Issue :
9
Database :
Academic Search Index
Journal :
Reumatología Clínica
Publication Type :
Academic Journal
Accession number :
153237827
Full Text :
https://doi.org/10.1016/j.reuma.2020.05.010